Design Therapeutics Overview
Design Therapeutics Target Price
Analysts' 12-month price predictions for DSGN.
Get informed when a big investor buys or sells
+ FollowShare Price
$13.52
Average Target Price
$20.50
51.6% upside
51.6% upside2 analysts in the last 4 months
High: $21 | Low: $20
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-04 | Oppenheimer | $21 | 55.3% upside |  |
| 2026-04-29 | Piper Sandler | $20 | 47.9% upside | |
| 2026-01-07 | Oppenheimer | $18 | 33.1% upside | |
| 2025-12-03 | Craig-HallumAdam Vogel | $15 | 10.9% upside | |
| 2025-12-03 | Leerink PartnersJoseph Schwartz | $14 | 3.6% upside | |
| 2024-05-07 | Piper SandlerYasmeen Rahimi | $12 |  11.2% downside | |
| 2023-08-15 | RBC CapitalLeonid Timashev | $7 | 48.2% downside | |
| 2022-12-07 | Piper SandlerYasmeen Rahimi | $42 | 210.7% upside | |
| 2022-05-02 | RBC Capital | $30 | 121.9% upside | |
| 2022-01-19 | Goldman SachsMadhu Kumar | $10 | 26% downside | |